Get the latest tech news

Type 2 diabetes drug associated with 35% lower risk of dementia, study finds

Large Korean study suggests sodium-glucose cotransporter-2 inhibitors, may lower the risk of dementia

Now a large Korean study published in the BMJ has suggested that a medicine used to treat type 2 diabetes, called sodium-glucose cotransporter-2 (SGLT-2) inhibitors, may lower the risk of dementia. The authors cautioned that this is an observational study and so could not prove cause and effect, but concluded that repurposing existing drugs to treat diseases that cause dementia “is one that has huge potential”, although further trials were needed to confirm their findings. An earlier version accurately reported the research as finding that SGLT-2 inhibitors may lower the risk of dementia, but in two instances incorrectly said it may “prevent” the condition.

Get the Android app